Log In
Print
BCIQ
Print
Print this Print this
 

GLPG1205

  Manage Alerts
Collapse Summary General Information
Company Galapagos N.V.
DescriptionUndisclosed molecule
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Inflammation (unspecified)
Indication DetailsTreat inflammatory disorders
Regulatory Designation

Partner

Johnson & Johnson


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today